Compare Novartis AG (NVS) vs Nuscale Power Corporation (SMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Nuscale Power Corporation — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Nuscale Power Corporation trades at $8.82 (market cap $2.76B). The key difference: Novartis AG is far larger — about 105.2× Nuscale Power Corporation's market cap, and Novartis AG pays a 3.17% dividend while Nuscale Power Corporation pays none. Which is the better fit depends on your goals.
| NVS | SMR | |
|---|---|---|
Market Cap | $290.25B | $2.76B |
Sector | Health | Utilities |
52-Week High | $168.62 | $53.43 |
52-Week Low | $113.50 | $7.64 |
Enterprise Value | $330.27B | $1.87B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →
